2 citations
,
October 1985 in “Pediatrics in review”
This review discusses various scalp-specific dermatoses, categorizing them by congenital, acquired, and hair loss-related conditions, but reports no new clinical findings.
44 citations
,
November 1998 in “Australasian Journal of Dermatology”
This review provides a framework for diagnosing acquiredscalp alopecias and discusses both non-scarring and scarring types, but reports no new clinical results.
September 2014 in “Turkish Journal of Dermatology”
This study found that non-scarring acquired alopecias were the most common hair and scalpdiseases among children visiting a pediatric dermatology outpatient clinic.
32 citations
,
August 2015 in “Anais Brasileiros de Dermatologia”
This review discusses the side effects and diseases related to hairstyles and hair treatments among black women, highlighting the need for thorough examination by dermatologists, but reports no new clinical results.
January 2026 in “International Journal of Dermatology”
This study reports two cases where acquired perforating dermatosis was localized to the scalp and coincided with acute diffuse alopecia, suggesting perifollicular inflammation may link the two conditions.
Hair loss is linked to cellular physiology and the IGF-1 to TGF-B1 ratio, not just androgen sensitivity. The theory lacks evidence, while finasteride and minoxidil are effective treatments.
Way-316606 is considered a potential hair loss treatment but is avoided due to safety concerns and lack of research. Minoxidil and Finasteride are preferred as established treatments.
A young man faces severe hair loss in his early 20s, using treatments like dutasteride and minoxidil with little success, impacting his self-esteem and relationships. He considers hair systems and therapy as potential solutions.
Finasteride and Dutasteride do not cause depression or "Post Finasteride Syndrome," with concerns often linked to the nocebo effect and preexisting mental health issues. The EU is unlikely to ban these drugs, but access may become more restricted due to ongoing debates.
Bee venom at 0.001% concentration was more effective than 2% minoxidil in promoting hair growth in mice, possibly due to increased growth factors and reduced inflammation. Caution is advised due to potential allergic reactions and the reliance on animal data.